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In a previous communication (1) it was shown that extensive pneu- 
monia associated with unrestrained multiplication of the organisms 
may be produced regularly in guinea pigs by the intratracheal injection 
of sublethal doses of certain toxic autolysates (pneumotoxin) mixed 
with sublethal doses of living pneumococci.  Neither the pneumococci 
alone nor the toxic autolysate alone produced a comparable condition. 
In the present paper, experiments are reported which demonstrate 
(a)  that  under certain conditions,  anti-autolysate  sera prepared in 
rabbits or horses by immunization with sterile filtrates of pneumotoxin 
prevent the development of pneumonia in animals  inoculated with 
mixtures of pneumococci and autolysate; (b) that theprotection against 
the development of pneumonia exhibited by these sera is heterologous, 
at least as regards Types I and  II;  (c)and that certain anti-pneumo- 
coccus horse sera used in the treatment of pneumonia in man contain 
either  no  heterologous  pneumonia-preventing  antibodies  or  slight 
amounts only. 
EXPERIMENTAL 
M atwds 
Immunization  of Animals.--Rabbits were immunized over a  period of 2  or 3 
months  by  intracutaneous,  subcutaneous  or  intravenous  injections  of  sterile 
Berkefeld filtrates of the toxic autolysates from either Type I  or Type II pneumo- 
cocci, each rabbit being inoculated with the autolysate of one type only.  The 
horses were immunized with subcutaneous injections of either  mixed autolysate 
filtrates from Pneumococcus I, II and III or with mixed autolysates and the living 
organisms of all three types.  The anti-antolysate sera from the horses were con- 
centrated and  refined by the usual methods  and  in  this  form  tested for  their 
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pneumonia-preventing properties.  Normal  rabbit  or  normal  horse  sera  were 
used as serum controls in the work. 
The pneumococcus strains--Types I and II--were the same as those used in our 
previous work.  A strain of Pneumococcus III was also used.  This was isolated 
from a patient with pneumonia in the Presbyterian Hospital in May, 1928.  The 
method of preparing the toxic autolysates has  been described in previous papers 
(1, 2).  Only those filtrates from Types I, II and III were us'ed which would kill 
guinea pigs within 24 hours in doses of 0.2 cc. when injected intratracheaUy. 
Young guinea pigs weighing from 190 to 250 gm. were used, and owing to the 
fact that  the  susceptibility to  the  autolysate usually varies inversely with  the 
weight of the pig, it was found important to have the animal in each experiment as 
nearly the same weight as possible. 
The injections of serum were given intraperitoneally 14  to  24 hours before the 
intratracheal infecting dose of pneumococci and  autolysate.  At first, the rabbit 
immune sera were given intrapetitoneally 24  hours  previous to the intratracheal 
dose of organisms and pneumotoxin, but some of these sera caused the development 
of anaphylactoid reactions immediately after the intratracheal inoculations.  In 
later experiments the serum injections were made 14 to 18 hours before the intra- 
tracheal dose and in  this way the  anaphylactoid reactions were avoided.  Our 
anti-pneumotoxic horse  sera have  never  given anaphylactic sensitization, even 
when the sera were given 24 hours before the infecting dose of toxin and pneumo- 
coccus  (3). 
Intratracheag Injections.--In carrying out the pneumonia preventing tests, the 
proper adjustment of the doses of pneumotoxin  and pneumococcus is essential. 
The dose ef pneumococcus used was about one half that which would cause death 
from septicemia when injected intratracheally without mixture with autolysate. 
The same principle governs the dose of autolysate usedin these experiments.  The 
amount employed was one half the quantity necessary to kill a pig of  approxi- 
mately the same weight in 24 hours.  With experience as to the virulence of the 
culture and the strength of the autolysate, it is comparatively easy to obtain the 
proper amounts of autolysate and pneumococci for these experiments. 
The intratracheal injections were carried out as follows  :--An 18-24 hour broth 
culture of the pneumococcus was diluted with broth to the strength desired.  This 
tube, containing the diluted pneumococcus culture, was kept in ice water through- 
out the experiment. 
A  tube containing the toxic filtrate was chilled, the vaseline seal opened, and 
the filtrate pipetted into a narrow, chilled tube.  This tube, containing the toxic 
autolysate, was also kept in ice water throughout the experiment.  Just before the 
injection, 0.2 cc. of the diluted pneumococcus culture and 0.2 cc. of the autolysate 
were  pipetted into  another iced tube,  mixed,  and 0.2  cc.  of  the  mixture  was 
drawn into an iced syringe and immediately injected intratracheally into a guinea 
pig.  A  fresh mixture was always prepared for each  injection and the same pre- 
cautions as to chilling, etc., were carried out with both control preparations  con- 
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Protective Action of Anti-autolysate Sera Against the Pneumonia Caused 
by  Pneumococci  Plus  Toxic  Filtrates  of  Homologous  Type 
Table I  demonstrates the protective action of two preparations of 
concentrated anti-autolysate horse sera against pneumonia caused by 
mixtures of toxic autolysate Type I  and living pneumococcus Type I. 
This experiment shows that two pigs injected intraperitoneally with 
1 cc. each of normal horse serum 18 hours previous to the inoculation of 
TABLE  I 
Action of  A nti-autolysate Sera in the Prevention of  the Pneumonia Caused by 
Pneuraococci and Toxic Filtrates of Homologous Type 
Pneumococcus culture Type I; very slight  growth.  Autolysate from Type I. 
0.2 co. pneumococcus,  Type I  culture  +  0.2 co. aatolysate.  0.2 ec. inoculated 
intratracheaUy;  Concentrated autolysate horse 30336.  9/24/28.  Concentrated 
autolysate horse 30337.  Normal horse serum. 
No. 
55 
58 
69 
61 
64 
54 
56 
65 
ST! 
60 
Wt.  Intraperitoneal 
injection 10/1 
238  1  cc.  normal 
horse serum 
230  1 cc. 30336 
232  1 cc. 30337 
226 
224 
230  1  cc.  normal 
!  horse serum 
232  1 cc. 30336 
238  1 cc. 30337 
222 
222 
Intratrscheal injection 
1o/2 
Pn. +  autolysate 
Pn. +  autolysate 
Pn. +  autolysate 
Broth +  autolysate 
Pn. +  broth 
Pn. +  autolysate 
Pn. +  autolysate 
Pn. +  autolysate 
Broth +  autolysate 
Pn. +  broth 
Symp- 
toms 
+++ 
0 
0 
+ 
0 
+++ 
o 
o 
+++ 
0 
Died or 
survived 
D. 3 days 
S° 
S. 
S. 
S. 
D. 2 days 
S. 
S. 
S. 
S. 
Cultures 
Heart  Lung 
+++  +++ 
+++  +++ 
--  m 
Exten! 
of lu~ 
como~ 
dation 
++ 
++-I 
pneumococci and toxic autolysate died in 2  and 3  days respectively, 
with pneumonia and  septicemia; while four pigs previously prepared 
with  1  cc.  each of two preparations  of concentrated  anti-autolysate 
sera remained well.  The difference in the appearance of the protected 
and  unprotected  animals was  striking.  18  hours  after  the  intra- 
tracheal injection of pneumococcus and autolysate the two pigs which 
had received the normal serum were severely dyspnoeic and appeared 
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serum had normal respiration and appeared well.  The two pigs which 
were injected with the autolysate and broth were dyspnoeic, one being 
desperately sick for 8 days but finally recovering; while the two which 
were injected with the pneumococcus broth culture remained well. 
Serum preparation 30336 was obtained from two horses immunized 
with  toxic autolysate filtrates  and  contained no  specific  protective 
substances.  Serum preparation 30337 was obtained from two horses 
immunized with toxic autolysates and living pneumococci and pro- 
tected Pn. 1,10-t  The question of the importance of pneumococcus 
specific protective properties in these experiments will be considered 
later. 
Protective Action of Anti-autolysate  Sera on the Pneumonia Caused  by 
Pneumococci Plus Toxic Filtrates  of a Heterologous Type 
That the pneumonia preventing action of our anti-autolysate sera is 
heterologous as regards pneumococcus Types I and II has been demon- 
strated  conclusively many times.  These  experiments were  carried 
out with anti-autolysate sera produced in rabbits by the immunization 
with autolysates of one type only (Type I or Type II).  The experi- 
mental pneumonia in each instance was caused by the autolysate and 
pneumococci of heterologous strains (Type I or II).  Table II demon- 
strates the preventive action of Type I anti-autolysate serum against 
pneumonia caused by pneumococcus and autolysate Type II, and is 
self  explanatory.  The same pneumonia-preventing action has been 
demonstrated  for  rabbit  anti-auto!ysate  Type  II  sera  against  the 
pneumonia caused by injections of Pneumococcus I  toxin and living 
pneumococcus I. 
These experiments therefore demonstrate that our anti-pneumotoxic 
sera are definitely  protective against pneumonias caused by mixtures of 
pneumococci and autolysates of a heterologous strain. 
Action of the Anti-pneumococcus  Sera Used in the Treatment  of Human 
Pneumonia  for  the  Pneumonia-preventing 
Heterologous  Substances 
In testing the anti-bacterial pneumococcus sera for the presence of 
the pneumonia-preventing substances which have been shown to be 
present in our anti-autolysate sera, it was important to rule out the JULL~ T.  PARKER  165 
effect of the specific protective substances which all these anti-bacterial 
sera contain.  To accomplish this, it was only necessary to test out the 
efficacy of these sera against the pneumonia produced by a  pneumo- 
coccus and autolysate from a heterologous strain. 
Table III gives one of our experiments of this kind.  It is seen that 
the serum concentrated by the Felton method shows no heterologous 
pneumonia-protective  powers;  the  serum  produced  by  the  Zinsser 
TABLE  II 
Action of an A nti-autolysate Serum in Preventing Pneumonia Caused  by Pneumococci 
Plus Toxic Filtrates of a tteterologous  Type 
Pneumococcus  II---good  growth.  Diluted  1-10 with  broth  Autolysate II. 
0.3 cc. In. IX dilution +  0.1 cc. autolysate.  0.2 cc. mixture injected.  Controls: 
(a) 0.3 cc. Pn.  +  0.1 co. broth--0.2 co. injected.  (b)  0,3 cc. broth  +  0.1  cc. 
autolysate  0.2 co. injected.  Rabbit serum 7-54, Anfi-autolysate  I. 
10-11 
8-74 
8-88 
8-89 
10-09 
8-87 
10-06 
No.  Wt. 
2O4 
202 
204 
210 
206 
200 
206 
Intraperitoneal 
injection 5/9 
2  CC.  normal 
rab. 
2 cc.  7-54 
2 cc. 7-54 
Intratracheal injection I Syrup- 
s/to  .  ~oms 
Pneumococcus  ÷  ]÷+-~ 
autolysate  I 
Pneumococcus  ÷  [  0 
autolysate  I 
Pneumococcus  ÷  I  0 
autolysate  J 
Pneumococcus ÷  [÷÷"}" 
autolysate  ] 
Pneumococcus  ÷  1-4--4--{- 
autolysate  [ 
Broth  q-  auto-]  0 
lysate  [ 
Pneumococcus  I  0 
and broth  I 
Died or 
survived 
D. 40 hrs. 
S. 
S. 
D. 40 hrs. 
D.  18 hrs. 
S. 
S. 
Cultures 
He~t  L~ 
++++++ 
+++4++ 
+  +++ 
Extent 
of lun~ 
consoll- 
dation 
+++ 
÷E+ 
+++ 
method shows a slight amount (protected one of the two pigs injected), 
while the rabbit anti-autolysate serum gives perfect protection.  The 
same  results  were  obtained  in  another  experiment  carried  out  in  a 
similar way.  Still an'other anti-pneumococcus serum used in treating 
human pneumonia was tested for heterologous pneumonia-preventing 
substances, and proved to be even weaker in these properties than the 
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These  experiments  demonstrate  how  poor  in  heterologous  anti- 
pneumonia antibodies the ordinary anti-bacterial pneumococcus sera 
are.  The explanation for the complete absence of these antibodies in 
the serum produced by the Felton method is probably to be found in 
its method of preparation, which concentrates the specific protective 
TABLE  III 
Action of Certain Anti-pneumococcus Sera Used in the Treatment of Human 
Pneumonia in Preventing  the Pneumonia Caused by Autolysate  and 
Pneumococei of a Heterologous Type 
Pneumococcus Type II; slight growth on broth.  Autolysate Type II.  0.2 ee. 
Pn. culture +  0.2 cc. autolysate.  0.2 co. injected.  Controls:  Pn.  +  broth and 
autolysate and broth•  Sera:  Felton's antibodies I; Zinsser  anti-pneumococcus 
serum; Rabbit 7-54; Anti-autolysate I. 
No.  Wt. 
7-5~ 200 
7-77 200 
7-67 200 
7-78 205 
7-73 2O0 
7-66 200 
7-69 195 
7-75 200 
7-71 19~ 
7-80 195 
7-74 19C 
Intraperitoneal 
injec~on 3/2 
Intratracheal injection 
3/3 
Pn.+autolysate 
Pn. +  autolysate 
Pn. +  aut~lysate 
2  cc.  Felton 
antibodies 
Same 
2  cc.  Zinsser 
$eruIn 
Same 
2 cc. 7-54 
2 cc. 7-54 
2  cc.  normal 
horse 
2  cc.  normal 
rabbit 
Pn. +  autolysate 
Pn. +  autolysate 
Pn. +  autolysate 
Pn. +  autolysate 
Syrup-  Died or 
toms  survived 
+++  D.  2 hrs. 
+++  D.  2 days 
0  S. 
+++  D. 40 hrs. 
++  s. 
+  S. 
+++  D.  18 hrs. 
Pn. +  autolysate  -k-b-I-  D.  5 hrs.  0 
Pn. +  autolysate  n  u +-[-  D.  40 hrs. + + + 
Broth  +  auto-  +  S.  -- 
lysate 
Pn. +  broth  0  S.  -- 
Cultures 
Heart  Lung 
o  + 
++  +++ 
++  ++-~ 
+++  ++-~ 
+ 
++4 
Extent 
of lu.~g 
consoli- 
dation 
++ 
+++ 
+++ 
+-{-+ 
++ 
-{--{-+ 
bodies in the globulin fraction of the serum and discards that part  of 
the serum which contains neutralizing antibodies (the pseudoglobulin 
fraction.) 
It is logical to suppose that a  serum containing specific protective 
antibodies, would have a preventive effect by its antibacterial proper- 
ties, on the pneumonia caused by the homologous type of organism and 
autolysate; and that this preventive effect would correpond closely to JULIA T.  rAXr~R  167 
the amounts of specific protective substances which these sera contain. 
This was found to be the case.  The serum produced by the Felton 
method, containing 1000 protective units, protected 75 per cent of the 
animals injected; the Zinsser serum protected 50 per cent, and the other 
Anti-pneumococcus I  serum only delayed death in one instance.  To 
save space, a table giving the details of these experiments is omitted. 
Protective Effect of Normal Rabbit or Horse Serum 
Occasionally normal rabbit serum protects against the pneumonia 
produced by a  mixture !of living pneumococcus and autolysate.  We 
believe this to be due to a non-specific reaction induced by the foreign 
serum in a  small percentage of the injected pigs (about 8 per cent). 
Horse  serum occasionally shows this non-specific protective action. 
Stillman had the same experience in his pneumococcus work in mice. 
He found that normal rabbit serum injected intraperitoneally in mice 
sometimes  protected  them  from  pneumococcus infections.  These 
rabbit sera contained no pneumococcus specific protective substances 
(4). 
The Content of Pneumococcus Specific Protective Substances in the Anti- 
autolysate  Sera 
That the pneumonia-preventing properties of anti-autolysate sera 
are not related to the pneumoeoccus  specific protective substances was 
demonstrated conclusively by the fact that the anti-autolysate  sera 
are equally effective against a pneumonia due to the toxin and pneu- 
mococci of either a  heterologous or homologous strain.  We also ti- 
trated all our rabbit anti-autolysate sera and in no instance did they 
show the presence of specific protective substances for mice.  Neither 
were there specific protective substances in horses immunized  with the 
autolysate filtrates, but protective substances for pneumococci  Types I 
and II were present in small amounts in the sera obtained from the 
horses which had been injected with living pneumococcus Types I, II 
and III, in addition to the autolysates. 
DISCUSSION 
The experiments reported in this paper appear to indicate that under 
certain conditions the sera produced in rabbits or horses by immuniza- 168  PNEUMONIA  IN GUINEA  PIGS.  II 
fion with Berkefeld filtrates of certain anaerobically produced autoly- 
sates of pneumococcus Type I  or II protect against the pneumonia 
caused in  guinea pigs by the intratracheal  injection of mixtures of 
living pneumococci and toxic autolysates.  Since the sera contain no 
specific anti-bacterial  antibodies, it is  evident that  their protective 
action must be due to some other form of immune body.  The immune 
body present  differs also  from the  specific  anti-bacterial  bodies in 
that it is apparently identical for both Types I and II of the pneumo- 
cocci and is therefore not type specific. 
Whether  this  lung-toxic  substance  is  produced  in  spontaneous 
pneumonia, or  in  the experimental pneumonia produced by  intra- 
tracheal injections of pneumococci alonc  as in the dog or monkey-- 
is a question which cannot be answered at present.  The demonstra- 
tion that a toxic substance of this nature is present in these conditions 
would help to explain some of the obscure features of pneumococcus 
pneumonia in animals and man. 
In the production of curative sera for lobar pneumonia, most of the 
efforts have been devoted to obtaining sera with a  high content of 
specific protective antibodies against living organisms, but Cecil and 
Blake (5) have found that the serum of a monkey may be completely 
free of any specific protective substance and yet be highly immune to 
pneumonia.  The reverse was also found to occur.  A monkey whose 
serum may protect mice against 100 to 1000 M.L.D.'S of pneumococci 
may still be susceptible to the homologous  pneumococcus  pneumonia. 
In connection with this work, it is also of interest to note that Cecil 
and Blake demonstrated that resistance to experimental pneumonia in 
monkeys is to  some degree  species specific as  regards pneumococci 
Types I, II and III  (6).  Stillman (7)  has come to the same conclu- 
sion in his work on the production of pneumococcus pneumonia in 
mice by the inhalation method.  He found that mice which had been 
rendered immune to one type of pneumococcus (Type I) by the inhala- 
tion method, may show an increased resistance locally when exposed 
to  infection by  the  same method with  organisms of  another  type 
(Type II). 
CONCLUSIONS 
1.  Anti-pneumotoxic sera prepared in rabbits or horses by immuni- 
zation with sterile filtrates of the pneumotoxin, under certain condi- JULIA T.  PARKER  169 
tions  protect  against  the  pneumonia  caused  by  the  intratracheal 
injections of mixtures of living pneumococci and toxic autolysates. 
2.  The protection against the development of pneumonia is heterol- 
ogous,  at  least  as regards Type I,  Type II, viz.:  an anti-autolysate 
serum prepared by the immunization with a  pneumotoxin  from one 
type of pneumococcus will prevent  the  development of  pneumonia 
caused by the injection of pneurnococci and autolysate from another 
type. 
3.  Certain anti-pneumococcus horse sera used in the treatment of 
pneumonia in man, either contain no heterologous pneumonia-prevent- 
ing antibodies or slight amounts only.  These sera, however, protect 
against  the  pneumonia produced by  injections of pneumococci and 
pneumotoxin  of  the  homologous  strain,  the  degree  of  protection 
depending on the amount of specific protective substances such sera 
contain. 
4.  Anti-pneumotoxic  sera  produced  in  rabbits  or  horses  by  the 
injection of sterile Berkefeld filtrates of the toxic autolysates contain 
no pneumococcus specific protective substances. 
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